InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-07-10 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
No financial data available for ARGX.
Company may not file with SEC or CIK is unresolved.
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
High Growth Tech Stocks in Europe with Promising Potential
European Equities Traded in US as ADRs Ease in Thursday Trading
J&J's Imaavy demonstrates long-term disease control in myasthenia gravis
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading
A Look At argenx (ENXTBR:ARGX) Valuation After New VYVGART Data At The 2026 AAN Meeting
The Bull Case For argenx (ENXTBR:ARGX) Could Change Following New VYVGART Ocular MG Efficacy Data
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
Amgen: MariTide And Osteoporosis Sales Fuel The Rally